Chronic and Episodic Headache
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic and Episodic Headache trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic and Episodic Headache trials you may qualify forThe main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
Migraine and/or Cluster Headache: Study Overview \*\*Background:\*\* Migraine and cluster headache are two primary headache disorders that significantly impact…
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The st…
This is a prospective, randomized, open-label, delayed-start clinical investigation evaluating the safety and efficacy of the Walther System, a Class IIa invest…
Headache, in its episodic and chronic forms, cannot be considered solely as an isolated neurological symptom, but as a complex condition of a bio-psycho-social…
The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene…
The goal of this clinical trial is to evaluate whether a multimodal physiotherapy program and guided meditation using a mobile app can help reduce headache pain…
Migraine is one of the most prevalent neurological disorders and is associated with a substantial individual and societal burden. In chronic migraine, central a…